Catarina Ribeiro Freitas

Dr. Catarina Ribeiro Freitas

Veterinary Sciences, University of Trás-os-Montes and Alto Douro, Vila Real, Portugal
orcid

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 July 2026 in Pathogens
Verified
Journal Article
Open access
PDF file
Catarina Ribeiro FreitasCatarina Ribeiro Freitas
Catarina Ribeiro Freitas
JPJosé Eduardo Teixeira Pereira
José Eduardo Teixeira Pereira
ECEliana Costa
Eliana Costa
OAOlga Alves
Olga Alves
Gilberto IgrejasGilberto Igrejas
Gilberto Igrejas
Vanessa SilvaVanessa Silva
Vanessa Silva
Coagulase-negative staphylococci (CoNSs) are major opportunistic pathogens in healthcare settings, particularly affecting immunocompromised patients and those with indwelling medical devices. Their growing antimicrobial resistance and ability to form biofilms present significant therapeutic challenges. This study analyzed 148 clinical CoNS isolates to determine species distribution, antimicrobial resistance, resistance genes, and biofilm production. Staphylococcus epidermidis was the most prevalent species (49.3%), followed by Staphylococcus hominis (27.0%) and Staphylococcus capitis (6.8%). Penicillin (83.8%), erythromycin (72.3%), and cefoxitin (66.2%) showed the highest resistance rates. Notably, 60.8% of isolates were resistant to fusidic acid and 45.3% to clindamycin, with inducible resistance in 12.1%. Among aminoglycosides, tobramycin resistance (45.3%) was most frequent. Resistance to ciprofloxacin and trimethoprim–sulfamethoxazole reached 45.9%, while mupirocin resistance was 17.6%. Among isolates resistant to penicillin and/or cefoxitin (n = 128), the mecA gene was detected in 69.5%; the mecC gene was absent. Only 38.5%% of mupirocin-resistant isolates carried the mupA gene. Trimethoprim resistance was mainly associated with dfrA (60.3%) and dfrG (14.7%). Biofilm super-producers accounted for 64.9% of isolates and non-producers for 7.4%, with no significant link between biofilm formation and antibiotic resistance. These findings reinforce the clinical relevance of multidrug-resistant, mupirocin-resistant, and biofilm-forming CoNSs, underscoring the need for improved surveillance and infection control.

17 July 2025 in Veterinary Sciences
Verified
Journal Article
Open access
PDF file
JRJessica Ribeiro
Jessica Ribeiro
Vanessa SilvaVanessa Silva
Vanessa Silva
Catarina Ribeiro FreitasCatarina Ribeiro Freitas
Catarina Ribeiro Freitas
PPPedro Pinto
Pedro Pinto
Madalena Vieira-PintoMadalena Vieira-Pinto
Madalena Vieira-Pinto
Patrícia PoetaPatrícia Poeta
Patrícia Poeta
Sternal bursitis is an underexplored lesion in poultry, often overlooked in microbiological diagnostics. In this study, we characterized 36 Escherichia coli isolates recovered from sternal bursitis in broiler chickens, combining phenotypic antimicrobial susceptibility testing, PCR-based screening, and whole genome sequencing (WGS). The genetic analysis revealed a diverse population spanning 15 sequence types, including ST155, ST201, and ST58. Resistance to tetracycline and ciprofloxacin was common, and several isolates carried genes encoding β-lactamases, including blaTEM-1B. Chromosomal mutations associated with quinolone and fosfomycin resistance (e.g., gyrA p.S83L, glpT_E448K) were also identified. WGS revealed a high number of virulence-associated genes per isolate (58–96), notably those linked to adhesion (fim, ecp clusters), secretion systems (T6SS), and iron acquisition (ent, fep, fes), suggesting strong pathogenic potential. Many isolates harbored virulence markers typical of ExPEC/APEC, such as iss, ompT, and traT, even in the absence of multidrug resistance. Our findings suggest that E. coli from sternal bursitis may act as reservoirs of resistance and virulence traits relevant to animal and public health. This highlights the need for including such lesions in genomic surveillance programs and reinforces the importance of integrated One Health approaches.